Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert James Glynn, Sc.D., Ph.D.

Co-Author

This page shows the publications co-authored by Robert Glynn and Jerome Avorn.
Connection Strength

7.235
  1. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol. 2006 Aug; 59(8):819-28.
    View in: PubMed
    Score: 0.341
  2. Sudden uncontrollable somnolence and medication use in Parkinson disease. Arch Neurol. 2005 Aug; 62(8):1242-8.
    View in: PubMed
    Score: 0.323
  3. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002 Sep 23; 162(17):2002-6.
    View in: PubMed
    Score: 0.265
  4. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology. 2001 Nov; 12(6):682-9.
    View in: PubMed
    Score: 0.249
  5. Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus. J Clin Epidemiol. 1999 Aug; 52(8):781-90.
    View in: PubMed
    Score: 0.213
  6. Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. Am J Epidemiol. 1999 Mar 15; 149(6):541-9.
    View in: PubMed
    Score: 0.207
  7. Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index. J Gerontol A Biol Sci Med Sci. 2018 06 14; 73(7):980-987.
    View in: PubMed
    Score: 0.197
  8. Old age and race as determinants of initiation of glaucoma therapy. Am J Epidemiol. 1993 Sep 15; 138(6):395-406.
    View in: PubMed
    Score: 0.142
  9. Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. BMC Med Res Methodol. 2012 Nov 26; 12:180.
    View in: PubMed
    Score: 0.134
  10. A randomized study of how physicians interpret research funding disclosures. N Engl J Med. 2012 Sep 20; 367(12):1119-27.
    View in: PubMed
    Score: 0.132
  11. False Claims Act prosecution did not deter off-label drug use in the case of neurontin. Health Aff (Millwood). 2011 Dec; 30(12):2318-27.
    View in: PubMed
    Score: 0.125
  12. The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels. J Am Coll Cardiol. 2011 Feb 15; 57(7):784-91.
    View in: PubMed
    Score: 0.118
  13. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol. 2010 Oct 01; 172(7):843-54.
    View in: PubMed
    Score: 0.114
  14. Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial. Am Heart J. 2009 Apr; 157(4):613-9.
    View in: PubMed
    Score: 0.103
  15. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care. 2007 Oct; 45(10 Supl 2):S131-42.
    View in: PubMed
    Score: 0.094
  16. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Med Care. 2007 Oct; 45(10 Supl 2):S38-43.
    View in: PubMed
    Score: 0.094
  17. Performance of propensity score calibration--a simulation study. Am J Epidemiol. 2007 May 15; 165(10):1110-8.
    View in: PubMed
    Score: 0.090
  18. Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making. 2006 May-Jun; 26(3):247-54.
    View in: PubMed
    Score: 0.085
  19. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. Clin Pharmacol Ther. 2006 Apr; 79(4):379-88.
    View in: PubMed
    Score: 0.084
  20. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol. 2005 Aug 01; 162(3):279-89.
    View in: PubMed
    Score: 0.080
  21. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension. 2005 Aug; 46(2):273-9.
    View in: PubMed
    Score: 0.080
  22. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol. 2005 May 01; 161(9):891-8.
    View in: PubMed
    Score: 0.079
  23. Suboptimal antidepressant use in the elderly. J Clin Psychopharmacol. 2005 Apr; 25(2):118-26.
    View in: PubMed
    Score: 0.079
  24. Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model. J Ment Health Policy Econ. 2004 Jun; 7(2):77-85.
    View in: PubMed
    Score: 0.074
  25. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med. 2004 May; 19(5 Pt 1):444-50.
    View in: PubMed
    Score: 0.074
  26. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation. 2004 May 04; 109(17):2068-73.
    View in: PubMed
    Score: 0.074
  27. Use of the case-crossover design to study prolonged drug exposures and insidious outcomes. Ann Epidemiol. 2004 Apr; 14(4):296-303.
    View in: PubMed
    Score: 0.074
  28. Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations. BMJ. 2004 Mar 06; 328(7439):560.
    View in: PubMed
    Score: 0.073
  29. How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004 Jan; 13(1):11-9.
    View in: PubMed
    Score: 0.072
  30. Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? Am J Med. 2003 Dec 15; 115(9):715-20.
    View in: PubMed
    Score: 0.072
  31. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003 Sep; 64(3):1046-9.
    View in: PubMed
    Score: 0.071
  32. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003 Aug; 38(4):1103-20.
    View in: PubMed
    Score: 0.070
  33. The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients. J Rheumatol. 2003 Apr; 30(4):792-8.
    View in: PubMed
    Score: 0.069
  34. Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry. 2002 Dec; 59(12):1147-54.
    View in: PubMed
    Score: 0.067
  35. Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. Control Clin Trials. 2002 Dec; 23(6):757-73.
    View in: PubMed
    Score: 0.067
  36. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002 Sep; 13(9):2353-62.
    View in: PubMed
    Score: 0.066
  37. Preventive health care measures before and after start of renal replacement therapy. J Gen Intern Med. 2002 Aug; 17(8):588-95.
    View in: PubMed
    Score: 0.066
  38. Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet. 2002 Jul 06; 360(9326):90.
    View in: PubMed
    Score: 0.065
  39. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002 Jul 24-31; 288(4):455-61.
    View in: PubMed
    Score: 0.065
  40. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002 Jul; 17(7):504-11.
    View in: PubMed
    Score: 0.065
  41. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002 Jul; 55(7):711-6.
    View in: PubMed
    Score: 0.065
  42. Late nephrologist referral and access to renal transplantation. Transplantation. 2002 Jun 27; 73(12):1918-23.
    View in: PubMed
    Score: 0.065
  43. Clozapine use and risk of diabetes mellitus. J Clin Psychopharmacol. 2002 Jun; 22(3):236-43.
    View in: PubMed
    Score: 0.065
  44. Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med. 2002 May 27; 162(10):1099-104.
    View in: PubMed
    Score: 0.065
  45. Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis. 2001 Dec; 38(6):1178-84.
    View in: PubMed
    Score: 0.063
  46. Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 2001 Dec; 49(12):1685-90.
    View in: PubMed
    Score: 0.063
  47. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001 Nov 01; 154(9):854-64.
    View in: PubMed
    Score: 0.062
  48. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001 Oct; 60(4):1547-54.
    View in: PubMed
    Score: 0.062
  49. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol. 2001 Oct; 38(4):969-76.
    View in: PubMed
    Score: 0.062
  50. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001 Oct; 38(4):809-14.
    View in: PubMed
    Score: 0.062
  51. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med. 2001 Aug 13-27; 161(15):1897-902.
    View in: PubMed
    Score: 0.061
  52. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001 Jun; 158(6):892-8.
    View in: PubMed
    Score: 0.060
  53. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med. 2000 Nov; 15(11):776-81.
    View in: PubMed
    Score: 0.058
  54. Failure of evidence-based medicine in the treatment of hypertension in older patients. J Gen Intern Med. 2000 Oct; 15(10):702-9.
    View in: PubMed
    Score: 0.058
  55. Which patients are treated for glaucoma? An observational analysis. J Glaucoma. 2000 Feb; 9(1):38-44.
    View in: PubMed
    Score: 0.055
  56. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) Am Heart J. 1999 Nov; 138(5 Pt 1):849-55.
    View in: PubMed
    Score: 0.054
  57. Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study. J Gerontol A Biol Sci Med Sci. 2019 07 12; 74(8):1271-1276.
    View in: PubMed
    Score: 0.053
  58. Definition of race and ethnicity in older people in Medicare and Medicaid. J Am Geriatr Soc. 1999 Jun; 47(6):730-3.
    View in: PubMed
    Score: 0.053
  59. Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care. 1998 Mar; 36(3):357-69.
    View in: PubMed
    Score: 0.048
  60. Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research study. J Comp Eff Res. 2018 01; 7(1):57-66.
    View in: PubMed
    Score: 0.048
  61. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol. 1997 Aug; 50(8):953-9.
    View in: PubMed
    Score: 0.046
  62. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997 Jul; 10(7 Pt 1):697-704.
    View in: PubMed
    Score: 0.046
  63. The impact of thiazide diuretics on the initiation of lipid-reducing agents in older people: a population-based analysis. J Am Geriatr Soc. 1997 Jan; 45(1):71-5.
    View in: PubMed
    Score: 0.045
  64. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996 Dec; 86(12):1805-8.
    View in: PubMed
    Score: 0.044
  65. Variability in length of hospitalization for stroke. The role of managed care in an elderly population. Arch Neurol. 1996 Sep; 53(9):875-80.
    View in: PubMed
    Score: 0.043
  66. The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons. J Gerontol A Biol Sci Med Sci. 1996 Mar; 51(2):M74-9.
    View in: PubMed
    Score: 0.042
  67. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents. Clin Pharmacol Ther. 1996 Jan; 59(1):83-92.
    View in: PubMed
    Score: 0.042
  68. Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people. J Am Geriatr Soc. 1995 Sep; 43(9):967-73.
    View in: PubMed
    Score: 0.041
  69. Epidemiologic and diagnostic aspects of bacteriuria: a longitudinal study in older women. J Am Geriatr Soc. 1995 Jun; 43(6):618-22.
    View in: PubMed
    Score: 0.040
  70. Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension. 1995 May; 25(5):1045-51.
    View in: PubMed
    Score: 0.040
  71. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA. 1994 Mar 09; 271(10):751-4.
    View in: PubMed
    Score: 0.037
  72. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994 Feb 28; 154(4):433-7.
    View in: PubMed
    Score: 0.037
  73. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med. 1994 Jan 10; 154(1):97-101.
    View in: PubMed
    Score: 0.036
  74. Topical glaucoma medications and cardiovascular risk in the elderly. Clin Pharmacol Ther. 1994 Jan; 55(1):76-83.
    View in: PubMed
    Score: 0.036
  75. Patterns of glaucoma medication use in the elderly: 1980-1990. J Glaucoma. 1994; 3(3):259-64.
    View in: PubMed
    Score: 0.036
  76. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. Am Heart J. 2014 Jan; 167(1):51-58.e5.
    View in: PubMed
    Score: 0.036
  77. Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings. J Am Heart Assoc. 2013 Jul 30; 2(4):e000208.
    View in: PubMed
    Score: 0.035
  78. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993 May; 83(5):711-6.
    View in: PubMed
    Score: 0.035
  79. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med. 1993 Feb 15; 118(4):273-8.
    View in: PubMed
    Score: 0.034
  80. Adverse pulmonary effects of topical Beta blockers used in the treatment of glaucoma. J Glaucoma. 1993; 2(3):158-65.
    View in: PubMed
    Score: 0.034
  81. Bias in comparative effectiveness studies due to regional variation in medical practice intensity: a legitimate concern, or much ado about nothing? Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e61-4.
    View in: PubMed
    Score: 0.033
  82. Propensity score calibration in the absence of surrogacy. Am J Epidemiol. 2012 Jun 15; 175(12):1294-302.
    View in: PubMed
    Score: 0.032
  83. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011 Dec 01; 365(22):2088-97.
    View in: PubMed
    Score: 0.031
  84. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health. 2011 Jun; 14(4):513-20.
    View in: PubMed
    Score: 0.030
  85. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf. 2011 Jun; 20(6):551-9.
    View in: PubMed
    Score: 0.030
  86. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011 Jul; 64(7):749-59.
    View in: PubMed
    Score: 0.029
  87. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf. 2010 Dec; 19(12):1248-55.
    View in: PubMed
    Score: 0.029
  88. NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib. Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1134-42.
    View in: PubMed
    Score: 0.027
  89. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009 Jul; 20(4):512-22.
    View in: PubMed
    Score: 0.026
  90. Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis Rheum. 2008 Aug 15; 59(8):1097-104.
    View in: PubMed
    Score: 0.025
  91. Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Am Heart J. 2008 Jul; 156(1):31-6.
    View in: PubMed
    Score: 0.025
  92. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 01; 51(13):1247-54.
    View in: PubMed
    Score: 0.024
  93. Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information. Med Care. 2007 Oct; 45(10 Supl 2):S158-65.
    View in: PubMed
    Score: 0.023
  94. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Am J Cardiol. 2007 Oct 01; 100(7):1061-7.
    View in: PubMed
    Score: 0.023
  95. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation. 2007 Jan 02; 115(1):27-33.
    View in: PubMed
    Score: 0.022
  96. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum. 2006 Sep; 54(9):2757-64.
    View in: PubMed
    Score: 0.022
  97. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum. 2006 May; 54(5):1378-89.
    View in: PubMed
    Score: 0.021
  98. Variable selection for propensity score models. Am J Epidemiol. 2006 Jun 15; 163(12):1149-56.
    View in: PubMed
    Score: 0.021
  99. Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors. J Clin Epidemiol. 2006 Jan; 59(1):18-25.
    View in: PubMed
    Score: 0.021
  100. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol. 2006 May; 59(5):437-47.
    View in: PubMed
    Score: 0.020
  101. Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model. J Clin Psychopharmacol. 2005 Oct; 25(5):427-34.
    View in: PubMed
    Score: 0.020
  102. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology. 2005 Jan; 16(1):17-24.
    View in: PubMed
    Score: 0.019
  103. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. J Clin Epidemiol. 2005 Jan; 58(1):98-102.
    View in: PubMed
    Score: 0.019
  104. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004 Jul; 148(1):99-104.
    View in: PubMed
    Score: 0.019
  105. Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth. 2003 Apr; 17(2):176-81.
    View in: PubMed
    Score: 0.017
  106. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy. J Clin Epidemiol. 2002 Feb; 55(2):121-8.
    View in: PubMed
    Score: 0.016
  107. Prophylactic use of factor VIII: an economic evaluation. Thromb Haemost. 1998 May; 79(5):932-7.
    View in: PubMed
    Score: 0.012
  108. Risk factors for non-insulin-dependent diabetes mellitus requiring treatment in the elderly. J Am Geriatr Soc. 1994 Dec; 42(12):1235-40.
    View in: PubMed
    Score: 0.010
  109. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 1994 Sep 14; 272(10):781-6.
    View in: PubMed
    Score: 0.009
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.